Investigation of atypical microbial agents in patients with sterile pyuria Authors: Elif Seren Tanrıverdi, Yusuf Yakupoğulları, Ayten Gündüz, Barış Otlu Published: 2026 ABSTRACT AbstractBackgroundTo determine the frequency of microbial DNA detection in patients with sterile pyuria and evaluate the association of leukocyte count and leukocyte esterase (LE) test results with physicians’ treatment decisions.MethodsThis prospective cross-sectional study was conducted over two months in the microbiology laboratories of two university hospitals. Urine samples from 201 patients with sterile pyuria (≥ 10 leukocytes/ml and/or LE positivity with negative urine culture) and 180 controls (no growth in culture and no pyuria) were analyzed. Multiplex PCR targeting 14 potential pathogens was performed. Demographic data, PCR results, and physicians’ treatment decisions were recorded. Chi-square tests and logistic regression assessed associations between laboratory findings and treatment decisions.ResultsPCR detected at least one potential pathogen in 50.2% of sterile pyuria patients compared to 10% of controls (p < 0.05). Treatment initiation was more frequent in the patient group than in controls (43.3% vs. 30%, p < 0.05). Logistic regression demonstrated that leukocyte counts ≥ 10/ml were significantly associated with PCR positivity (OR = 6.84, p < 0.05) and the physician’s treatment decisions (OR = 2.59, p < 0.05). The most common pathogens in patients were Ureaplasma urealyticum (21.9%), Mycoplasma hominis (12.9%), and Gardnerella vaginalis (10.9%), predominantly in adult women with both elevated leukocyte counts and positive LE tests. Although PCR positivity was significantly associated with treatment initiation, the correlation was weak (r = 0.33), indicating that treatment decisions were influenced by additional clinical factors.ConclusionsMolecular testing detected DNA from Ureaplasma, Mycoplasma, and G. vaginalis frequently in sterile pyuria, particularly in adult women; these findings indicate candidate microorganisms requiring clinical correlation.Keywords: Urinary tract infection, Pyuria, Mycoplasma, Ureaplasma, Gardnerella vaginalis Introduction Urinary tract infections (UTIs) are infections that occur in any part of the urinary tract, more commonly in the bladder and urethra, but also including the kidneys and ureters. Urinary tract infections are among the three most common inflammatory conditions in both community- and hospital-acquired infections, with approximately 150–400 million people worldwide diagnosed with UTIs each year; it has been reported that at least half of adult women [1–3] and 2–8% of children under the age of 10 experience UTIs annually [4]. The frequency and pathogen profile of urinary tract infections vary among patient groups depending on factors such as age, sex, sexual activity, hospitalization, catheterization, urinary stones, utero-vesical prolapse, vesicoureteral reflux, and other urinary system-related conditions [5, 6]. The laboratory diagnosis of urinary tract infections is mainly based on urinalysis and bacteriological culture, with the most frequently isolated pathogens being Escherichia coli, Klebsiella and Proteus species among Enterobacterales, non-fermentative Gram-negative bacilli such as Pseudomonas, Gram-positive cocci such as Staphylococcus saprophyticus and Enterococcus species, and Candida species in certain patient groups [5]. However, there are many more pathogens capable of causing infections in the urinary system that cannot be detected by conventional urine culture methods due to several reasons, primarily technical limitations and interpretive issues. These pathogens include anaerobic bacteria, Mycobacterium species, viable but non-culturable organisms (adapted to cell wall-deficient forms), Mycoplasma and Ureaplasma species, viruses, and obligate intracellular pathogens such as Chlamydia [7–9]. Due to the increasing antimicrobial resistance, the effectiveness of empirical treatments has declined, making accurate diagnosis of UTIs more important than ever [10]. Considering the high frequency of urinary tract infections in both community and hospital settings and the amount of antimicrobial drugs required for their treatment, studies aimed at improving diagnostic accuracy will not only address patients’ immediate clinical problems but will also contribute to controlling antimicrobial resistance, which has become a global emergency. However, achieving this goal requires the development and widespread use of diagnostic systems that allow for more comprehensive analysis of patients’ clinical and laboratory data, as well as the evaluation of these results to assess their potential contributions to routine clinical practice. This study aimed to identify microorganisms detected by real-time multiplex polymerase chain reaction (PCR) in patients with sterile pyuria and to assess how leukocyte count and leukocyte esterase influence clinicians’ decisions to initiate treatment. Materials and methods Study design This prospective cross-sectional study was conducted in the medical microbiology laboratories of Inonu University Turgut Ozal Medical Center and Turgut Ozal University Malatya Training and Research Hospital. Within the scope of the study, a total of 6,629 urine samples submitted with urinary system infection and related diagnostic codes from patients presenting to various outpatient clinics during the two-month period between September 1 and November 1, 2024, were evaluated. Of these 6,629 samples, 5,432 showed no significant growth in culture. Samples with no significant growth in urine culture but with ≥ 10 leukocytes/ml in uncentrifuged urine and/or leukocyte esterase positivity in urine dipstick test were considered sterile pyuria and subjected to further analysis [11, 12]. The control group consisted of patients with suspected urinary tract infection who had negative urine culture and a leukocyte count < 10/ml. Samples from patients who reported typical symptoms of urinary tract infection during their current visit to the physician and for whom a urine culture was ordered as part of the clinical evaluation and preliminary diagnosis of UTI were included in the study. Patients with an indwelling urinary catheter, documented urolithiasis, prior antimicrobial treatment within the previous three months, or any functional or anatomical disorder of the urogenital tract were excluded. Demographic data such as age and sex, whether the patient was diagnosed with urinary tract infection during their current admission based on medical procedures performed, and whether antimicrobial treatment was prescribed for this purpose were obtained from the hospital automation system records and evaluated within the scope of the study. Antibiotic prescription was based solely on the physician’s clinical assessment during patient evaluation, independent of PCR results, which were not available to clinicians at the time. Since the study used anonymized records and focused on diagnostic associations, antibiotic types were not individually collected; only whether treatment was initiated was recorded. Laboratory tests Urine culture, cell count, and biochemical analysis Midstream urine samples collected either from the first morning urine or from patients who had not urinated for at least 4 h, following appropriate pre-cleaning of the external urethra, were used for culture and urinalysis. All patients were instructed to perform perineal cleansing with sterile wipes prior to providing a midstream urine sample. Samples were inoculated onto blood agar and EMB agar media, incubated aerobically for 18–24 h, and then evaluated by the investigators. Urine samples were analyzed using a fully automated urine analyzer (BT Bio Corp., BT Uricell 1600, South Korea) with the dipstick method. From each urine sample evaluated in the study, 10 ml was transferred into 15 ml Falcon tubes and centrifuged at 4000 rpm for 30 min. The supernatant was discarded, and the remaining 1 ml at the bottom was divided into 2 ml Eppendorf tubes at 0.5 ml each. These samples were stored at -80 °C for molecular microbiological analyses. A total of 201 samples with no growth in culture but with ≥ 10 leukocytes in all fields and/or leukocyte esterase positivity in urine dipstick test were considered sterile pyuria and included in the patient group. A total of 180 samples from patients with no growth in urine culture, no significant leukocyte counts in urine for UTI, and negative leukocyte esterase results were included as the control group. Multiplex PCR The presence of a total of 10 bacteria (Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum, Ureaplasma parvum, Neisseria gonorrhoeae, Chlamydia trachomatis, Gardnerella vaginalis, Treponema pallidum, Haemophilus ducreyi, and Streptococcus agalactiae), two viruses (HSV-1/2), one yeast (Candida albicans), and one protozoon (Trichomonas vaginalis) was investigated by real-time multiplex PCR. For this purpose, DNA isolation was performed using the EZ1 Virus Mini Kit v2.0 (Qiagen, Germany) with the EZ1 Advanced XL (Qiagen, Germany) automated nucleic acid extraction system. Multiplex PCR targeting the selected microorganisms was performed using NeoPlex STI-14 (GeneMatrix Inc., South Korea) kits on the Rotor-Gene Q MDx 5Plex HRM (Qiagen, Hilden, Germany) real-time PCR device. The NeoPlex STI-14 kit includes an internal control targeting a housekeeping gene, which was amplified in each reaction to verify extraction efficiency and PCR validity. All microbiological procedures were performed by certified medical microbiology specialists working in the participating laboratories. Statistical analysis Statistical analyses were performed using IBM SPSS Statistics 26.0 software. The distribution of continuous variables was evaluated with the Kolmogorov-Smirnov test, and the Mann-Whitney U test was used for between-group comparisons of non-normally distributed variables. Pearson’s chi-square test or Yates’ corrected chi-square test, where appropriate, was applied for categorical variables such as sex, PCR result, and antibiotic use. Logistic regression analysis was performed to evaluate the relationship of leukocyte esterase positivity, leukocytes ≥ 10, and the combination of these two parameters with PCR test positivity and initiation of antibiotic treatment. A p-value < 0.05 was considered statistically significant. Results A total of 381 urine samples were analyzed, with a median patient age of 56 years (min-max = 0–90) and a female/male ratio of 223/158 (58.5%/41.5%). The median leukocyte count in the samples was 16/ml (min-max = 0–1474), the number of samples positive for at least one of the agents tested by PCR was 119 (31.2%), and the number of patients who received treatment based on their current medical evaluation was 141 (37%). The statistical comparison of demographic characteristics, urinalysis results, and treatment initiation status of the patient and control groups is shown in Table 1. The results indicated no significant difference between the two groups in terms of age and sex; however, the rates of detecting a positive agent by PCR and initiating treatment were found to be significantly higher in the patient group. Table 1Statistical comparison of the demographic characteristics, urinalysis results, and antimicrobial treatment status of participants in the patient and control groupsCharacteristicControl (n = 180)Patient (n:201) p Age (Year, median; min-max)50.5; 0–9058; 0–870.114*Sex (n; %) Female102; 56.7121; 59.10.571** Male78; 43.380; 40.9 Leukocyte count (Median; min-max)4; 1–934; 0-1474–Leukocyte esterase (n) Negative18019– 1+067 ≥2+0115PCR (n; %) Positive18; 10101; 50.2 < 0.001*** Negative162; 90100; 49.8Antimicrobial treatment (n; %) Given54; 3087; 43.3 0.032** Not given126; 70114; 56.7*Mann Whitney U test, **Pearson’s Chi-square test, ******Yates-corrected Chi-square test. Leukocyte count and leukocyte esterase tests were not statistically compared as they were parameters used to differentiate between the patient and control groups Statistical comparison of the demographic characteristics, urinalysis results, and antimicrobial treatment status of participants in the patient and control groups *Mann Whitney U test, **Pearson’s Chi-square test, ******Yates-corrected Chi-square test. Leukocyte count and leukocyte esterase tests were not statistically compared as they were parameters used to differentiate between the patient and control groups In the patient group, at least one possible pathogen was detected in 101 (50.2%) samples, whereas in the control group, a possible pathogen was identified in 18 (10%) samples. The most frequently detected microorganisms in the patient group were U. urealyticum (n = 44, 21.9%), M. hominis (n = 26, 12.9%), and G. vaginalis (n = 22, 10.9%), while in the control group, the most commonly detected microorganisms were U. urealyticum (n = 4, 2.2%), U. parvum (n = 3, 1.7%), and M. hominis (n = 3, 1.7%). The numerical distribution of microorganisms detected by PCR in the groups is shown in Table 2. Table 2Numerical distribution of pathogens detected by PCR in the patient and control groupsMicroorganismControl Group (n = 180)Patient Group (n = 201) Streptococcus agalactia 20 Trichomonas vaginalis 11 Ureaplasma parvum 37 Ureaplasma urealyticum 437 Gardnerella vaginalis 221 Mycoplasma hominis 321 Mycoplasma genitalum 12 Candida albicans 22HSV-201 Neisseria gonorrhoeae 01Multiple pathogen positivity08*TOTAL n(%)18 (10)101 (50.2)*U. urealyticum + M. hominis = 4U. urealyticum + C. trachomatis = 2G. vaginalis + M. hominis = 1U. urealyticum + M. genitalum + C. trachomatis = 1 Numerical distribution of pathogens detected by PCR in the patient and control groups *U. urealyticum + M. hominis = 4 U. urealyticum + C. trachomatis = 2 G. vaginalis + M. hominis = 1 U. urealyticum + M. genitalum + C. trachomatis = 1 The possible association of significant leukocyte count and leukocyte esterase positivity with PCR positivity and initiation of treatment was analyzed using logistic regression, and the results are presented in Table 3. Accordingly, a leukocyte count of ≥ 10, leukocyte esterase positivity, and the presence of both parameters together were found to be significantly associated with PCR test positivity. While leukocyte esterase positivity alone was not associated with initiation of treatment, the presence of a significant leukocyte count in urine, as well as having both a significant leukocyte count and positive leukocyte esterase result, were significantly associated with initiation of treatment. Correlation analysis revealed a low but significant linear correlation (r = 0.33) between treatment administration and PCR positivity. Within the sterile pyuria group, treatment initiation was significantly more frequent in PCR-positive patients compared to PCR-negative patients (p < 0.05). Table 3Logistic regression analysis of the association of leukocyte count ≥ 10, leukocyte esterase positivity, and their combination with “positive PCR result” and “treatment administration.VariableOR95% CI P (+) PCR (n:119) Leukocytes ≥ 10 6.843 3.690–12.691 < 0.001 LE (+) 3.173 1.852–5.436 < 0.001 Leukocytes ≥ 10 + LE(+) 3.149 1.888–5.251 < 0.001 (+) Treatment (n: 141) Leukocytes ≥ 10 2.592 1.542–4.354 < 0.001 LE (+)1.3400.819–2.1910.244 Leukocytes ≥ 10 + LE(+) 1.945 1.196–3.163 0.007 Logistic regression analysis of the association of leukocyte count ≥ 10, leukocyte esterase positivity, and their combination with “positive PCR result” and “treatment administration. Discussion Urinary tract infections (UTIs), along with respiratory tract infections, are among the most frequently diagnosed diseases worldwide for which antibiotic treatment is prescribed. Factors such as inadequate microbiological diagnosis, the interpretation of nonspecific patient symptoms in favor of UTI, the low sensitivity of urinalysis parameters in UTI diagnosis, the clinician’s level of knowledge and experience regarding UTI, and the patient’s personal characteristics (fear and exaggeration) have been associated with overdiagnosis and overtreatment of UTI [13–15]. Culture is the gold standard method for the diagnosis of urinary tract infections, and since this method is essentially based on the visual detection of a certain quantitative level of growth in a sterile body fluid, it is relatively technically easier than the culture-based diagnosis of infections in other body sites. However, factors such as the method and timing of sample collection, urethral-vaginal contamination, and the possibility of numerous bacteria, fungi, viruses, or protozoa that cannot be cultured by conventional methods being causative agents mean that a negative culture result does not exclude the diagnosis of UTI. This situation may lead to the initiation of treatment (and consequently potentially unnecessary or inappropriate antimicrobial use) by the clinician despite insufficient clinical and laboratory data, or the failure to establish the correct diagnosis in some patients. Studies have reported that inadequate diagnosis of UTI is one of the most important problems preventing patients from receiving appropriate treatment and that individuals who do not receive appropriate treatment may develop a range of serious complications such as urosepsis, pyelonephritis, acute and chronic kidney damage, cyst and abscess formation, renal scarring, and blood pressure abnormalities [16]. The diagnostic sensitivity of culture in patients with acute cystitis is around 60% [17]. In one study, metagenomic next-generation sequencing analysis of urine samples from patients presenting with UTI symptoms and diagnosed with UTI based on cell counts and urine biochemistry results detected more than twice as many uropathogens compared to culture, and while 70% of polymicrobial infections were detected by culture, 98% were identified by next-generation sequencing [18]. These data demonstrate the existence of a significant group of patients whose condition cannot be diagnosed by culture and who, therefore, cannot receive appropriate treatment, emphasizing the need for a more detailed investigation of these patients’ true condition. In this study, urine samples submitted to the laboratory for urine culture with urinary tract infection and related diagnostic codes were selected, and samples with no growth in culture but with significant leukocyte counts and/or leukocyte esterase positivity, defined as sterile pyuria, were included for further analysis. A total of 14 different possible pathogens were investigated in these samples, and compared to a control group with similar demographic characteristics, more than five times as many microorganisms were detected in these patients, with statistical significance. Approximately two-thirds of the patients had Ureaplasma and Mycoplasma species as single possible agents, and this proportion rose to about three-quarters when multiple detections were included. Ureaplasma and Mycoplasma are among the smallest free-living human pathogenic bacteria; since they lack a cell wall, they cannot be detected by Gram staining of clinical specimens and require special media and growth conditions for culture, making routine laboratory diagnosis difficult. The colonization of these two agents, especially in the vagina and urethra of both men and women, makes it challenging for clinicians to consider them as definitive pathogens. However, a systematic review of 377 studies recommended testing for Mycoplasma and Ureaplasma in patients with symptomatic sterile pyuria, chronic urethritis, overactive bladder, and interstitial cystitis, and providing appropriate treatment to those who test positive [19]. The 10% PCR positivity observed in the control group should not be interpreted as evidence of infection, but rather as background detection that likely reflects genital or urogenital colonization, subclinical carriage below a symptomatic threshold, and/or low-level contamination during sample collection despite standardized cleansing procedures. This background positivity highlights the clinical importance of the markedly higher rate (50.2%) detected in the sterile pyuria group and supports the potential clinical relevance of the microorganisms detected in symptomatic patients with pyuria, with clinical correlation required. In a study conducted in Türkiye, two-year retrospective data from 2,926 patients whose urine samples were sent to the laboratory for Mycoplasma and Ureaplasma detection were examined; significant levels (≥ 10^4 cfu/ml) of Mycoplasma and/or Ureaplasma were detected in approximately 27% of samples. In the same study, women were found to be three times more likely to be positive for these agents than men (32% vs. 11%), Ureaplasma alone was detected in 81.5% of positive samples, and at least 85% of positive cases were in individuals aged 18–65 years [20]. In our study, the most frequently detected pathogen by 101 PCR-positive patients with sterile pyuria was U. urealyticum (n = 44), and the overall prevalence of Mycoplasma and Ureaplasma species among all positive samples was 75%. Detailed examination of the cases in which these bacteria were detected revealed that 61.4% of patients were female and 38.6% male, only four patients were in the pediatric age group, while the remaining 71 (94.7%) patients were aged 20 years or older, and 59 (78.7%) of positive cases had both significant leukocyte counts and positive leukocyte esterase results. The findings of our study, together with the available literature, indicate that Mycoplasma and Ureaplasma species have an important place among possible pathogens in adult patients with sterile pyuria. A major limitation of this study is the use of qualitative PCR, which detects microbial DNA presence but cannot quantify pathogen load or definitively distinguish between active infection, colonization, or contamination. This is evidenced by the 10% PCR positivity rate in our control group (asymptomatic patients without pyuria), which likely reflects urogenital colonization, subclinical infection, or low-level contamination rather than symptomatic infection. The significantly higher rate in sterile pyuria patients (50.2%) suggests clinical relevance; however, quantitative PCR studies establishing pathogen load thresholds are needed to determine which positive results represent true causative infections requiring treatment. Until such thresholds are established, our findings should be interpreted as identification of candidate pathogens requiring clinical correlation rather than definitive etiologic diagnosis. Nevertheless, in routine clinical practice, it remains important for clinicians to carefully evaluate patients to avoid misinterpreting genital symptoms as urinary complaints and to ensure meticulous collection of urine samples to prevent possible vaginal contamination. Additionally, the multiplex PCR kit used in this study provides qualitative results only, which limits the ability to distinguish colonization from true infection. Future studies using quantitative PCR may help establish clinically relevant cut-off values. In our study, the most frequently detected possible pathogen after Mycoplasma and Ureaplasma species in PCR-positive samples was G. vaginalis, with 22 (10.9%) positive individuals in the patient group compared to 2 (1.1%) in the control group. This bacterium is another potential urinary pathogen that can frequently colonize the female genital tract. Although there are still differing opinions regarding its potential to cause urinary infections, bladder microbiome studies in symptomatic and recurrent UTI patients have shown that G. vaginalis plays an important role in the gut-vagina-bladder axis influencing urinary infection development in women and may be clinically relevant in symptomatic cases and should be interpreted in conjunction with clinical findings [21]. In our study, all 24 patients in whom G. vaginalis was detected were adults aged 21 to 85 years, and 6 (27.3%) of those positive in the patient group were men. This finding underscores that the presence of G. vaginalis is not limited to women and may also be clinically relevant in male patients presenting with sterile pyuria. Moreover, in the patient group, the highest frequency of concurrent significant leukocyte counts and leukocyte esterase positivity occurred in patients with G. vaginalis (n = 21, 95.5%). This finding supports the potential clinical relevance of G. vaginalis in patients with sterile pyuria. One of the interesting findings of our study was that more than one-quarter of Gardnerella-positive cases were male. A review of studies published since 1982 reported that the prevalence of G. vaginalis in male UTI cases varied between 0.5% and 27%, with most patients having urolithiasis, catheters, diabetes, or tumors, although healthy individuals were also affected. The review reported that having a sexual partner with Gardnerella-induced bacterial vaginosis was an independent risk factor for developing UTI due to the same pathogen in men [22]. An experimental study found that G. vaginalis induced a series of changes in gene expression in the bladder epithelium, leading to cellular and mucosal inflammation and predisposing to co-infections or superinfections with other uropathogens, particularly E. coli [23]. In light of current scientific data, our findings indicate that in symptomatic patients with pyuria where no other causative agent is identified, G. vaginalis may represent a relevant finding in symptomatic patients with pyuria. Beyond the methodological limitations discussed above, this study has several important limitations. The multiplex PCR assay provided qualitative rather than quantitative results, precluding pathogen load assessment and limiting the ability to distinguish colonization from active infection. Comorbidity and clinical-context data (including age, sex, diabetes, immunosuppression, and pregnancy status) were not available, which restricted adjustment for potential confounding variables in regression analyses. The study was conducted over a two-month period in a single geographic region, limiting assessment of seasonal variation and generalizability. Finally, the absence of follow-up clinical outcome data prevented direct evaluation of the clinical significance of PCR positivity. In the samples included in our study, Streptococcus agalactiae (n = 2) and Candida albicans (n = 4) were detected. However, despite their ability to grow in conventional culture, the negative culture results suggest that their amounts in the samples were too low to be considered significant. On the other hand, the detection of T. vaginalis in the urine of two patients (one in the control group), Neisseria gonorrhoeae in two patients, and HSV-2 in two patients (all in the patient group) was consistent with the negative culture results for these patients. Apart from these, the detection of multiple possible pathogens, mostly Mycoplasma and Ureaplasma species, in a total of 8 (4%) patients in the patient group and none in the control group was noteworthy. Another important finding of our study was the detection of Chlamydia in three (1.5%) patients—two women and one man aged 45 to 72 years—an important urethritis pathogen and sexually transmitted agent for which data on prevalence in Türkiye are limited. This finding highlights that C. trachomatis should not be overlooked in middle-aged and older adults, as it may contribute to sterile pyuria even in age groups where it is traditionally considered uncommon. In our study, the predictive value of significant leukocyte counts and LE positivity alone and in combination for PCR positivity and initiation of treatment was investigated. Among these, the presence of a significant leukocyte count alone was found to be the strongest parameter associated with both a positive PCR result and initiation of treatment (Table 3). This finding shows that the clinician who evaluated the patient clinically significantly considered the leukocyte count when diagnosing UTI, even when the culture result was negative. Considering that the administration of treatment may reflect the clinician’s strong conviction about the diagnosis, the data obtained in our study showed a low but significant correlation (r = 0.33) between treatment administration and PCR positivity. This result indicates that the clinician’s willingness to make a diagnosis and initiate treatment based on existing examination findings and test results at the time of patient evaluation was, to some extent, consistent with the data later obtained in this study. However, this does not imply that the choice of antimicrobials used in treating patients was sufficiently appropriate and also highlights the need for advanced diagnostic technologies to clarify the true status of patients with diagnostic challenges. Moreover, the weak association suggests that clinicians based their treatment decisions primarily on urinalysis parameters and clinical assessment rather than PCR results alone. The World Health Organization has declared the global rise in antimicrobial resistance a worldwide emergency, stating that humanity is entering a post-antibiotic era in which people could die from community-acquired infections due to increased resistance [24]. Many Gram-negative bacterial species, most of them important uropathogens, resistant to last-resort drugs, have been detected in Türkiye for many years [25–27]. In our study, antimicrobial treatment was initiated in 30% of control group patients and 43% of those defined as having sterile pyuria. Although the difference was statistically significant, the fact that approximately one-third of a group whose urine culture and urinalysis results did not support infection received antibiotics reinforces concerns about the appropriate use of these drugs. Therefore, in the management of infectious diseases, the importance of high-evidence-level laboratory findings is increasing to ensure appropriate antimicrobial use, one of the fundamental requirements for controlling rising resistance. Possible explanations for this finding include empirical treatment in patients presenting with persistent urinary symptoms despite negative laboratory results, treatment for suspected prostatitis or a gynecological infection, or physician concern about missing an evolving early infection. Conclusion In this study, the frequency of certain pathogens in urine samples from patients with sterile pyuria in two university hospitals in a medium-sized city in Türkiye was investigated, and Mycoplasma, Ureaplasma species, and G. vaginalis were frequently detected in patients with sterile pyuria in approximately half of the patients. Although the PCR method used had certain technical limitations, the coexistence of significant urinary inflammatory markers in PCR-positive patients supported existing scientific evidence regarding the potential clinical relevance of the identified species in well-defined patient groups. Considering the prevalence of urinary tract infections and the amount of antimicrobial drugs used globally for this diagnosis, strengthening the infrastructure of microbiology laboratories in line with advancing technology will make a significant contribution to the accurate diagnosis of cases with sterile pyuria. High-evidence-level test results obtained can also contribute to improving clinicians’ routine diagnostic and treatment practices in the long term. Acknowledgements We thank the microbiology laboratories and technical staff of two hospital for their assistance with sample processing and laboratory support. Abbreviations Urinary tract infection Leukocyte esterase Polymerase chain reaction Author contributions E.S.T: Writing—original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Y.Y.: Writing— review & editing, Writing—original draft, Supervision, Software, Project administration. A.G.: Validation, Software, Resources, Data curation. B.O.: Writing—review & editing, Writing —original draft, Supervision, Investigation. Funding No funding. Data availability Data are available on request from the corresponding author. Declarations Ethics approval and consent to participate This study was approved by the Non-Interventional Clinical Research Ethics Committee of Turgut Ozal University (decision no: 37, dated 27.12.2023). The study was conducted in accordance with the Declaration of Helsinki of 1964 and later amendments. As the study was designed a prospective cross-sectional study and used only anonymized laboratory results and anonymized records retrieved from the hospital automation system, without any patient identifiers, the Ethics Committee confirmed that informed consent was not required. In Türkiye, according to the Regulation on Clinical Research (2013) and the Personal Data Protection Law (KVKK), informed consent is not mandatory for non-interventional studies conducted with anonymized data. This practice is also consistent with international ethical standards for the use of de-identified health information, including the Declaration of Helsinki and GDPR principles. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement Data are available on request from the corresponding author.